This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/515258-hungary-china-covid19-vaccine-delivery/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
Hungary says 500,000 Sinopharm Covid-19 vaccines will arrive next week as Budapest hopes to inoculate 2 million by April Hungary says 500,000 Sinopharm Covid-19 vaccines will arrive next week as Budapest hopes to inoculate 2 million by April
(7 months later)
The Hungarian government has announced that a shipment of 500,000 Chinese Covid-19 jabs will arrive in the country next week, as Budapest looks to distance itself from Brussels’ stuttering vaccination program.The Hungarian government has announced that a shipment of 500,000 Chinese Covid-19 jabs will arrive in the country next week, as Budapest looks to distance itself from Brussels’ stuttering vaccination program.
“The country has contracts with the Russian and Chinese parties to increase vaccine procurement. More than 30 million people around the world have already been vaccinated with the Chinese vaccine and 500,000 doses will arrive in Hungary next week,” said Gergely Gulyas, the Prime Minister’s chief of staff, on Thursday. “The country has contracts with the Russian and Chinese parties to increase vaccine procurement. More than 30 million people around the world have already been vaccinated with the Chinese vaccine and 500,000 doses will arrive in Hungary next week,” said Gergely Gulyas, the Prime Minister’s chief of staff, on Thursday. 
Gulyas told reporters that the jab, developed by Sinopharm, will be tested on arrival and if approved, it will be ready for use as soon as possible. The prime minister’s chief of staff conceded that the jab did not come cheap, saying, “the price of the Chinese vaccine is over ten thousand forints, but that is not a consideration, because dozens of people still die today.”Gulyas told reporters that the jab, developed by Sinopharm, will be tested on arrival and if approved, it will be ready for use as soon as possible. The prime minister’s chief of staff conceded that the jab did not come cheap, saying, “the price of the Chinese vaccine is over ten thousand forints, but that is not a consideration, because dozens of people still die today.”
He also said that the country remains in talks with other vaccine manufacturers. He also said that the country remains in talks with other vaccine manufacturers. 
Gulyas said more than 300,000 jabs have been administered in Hungary so far and in the best-case scenario, the country hoped to vaccinate two million people before the end of March. “The end of April may be the earliest time we can vaccinate everyone, but that’s an optimistic scenario,” he added. Gulyas said more than 300,000 jabs have been administered in Hungary so far and in the best-case scenario, the country hoped to vaccinate two million people before the end of March. “The end of April may be the earliest time we can vaccinate everyone, but that’s an optimistic scenario,” he added. 
In January, Hungary became the first nation in the EU to register a Chinese-made Covid-19 vaccine amid very public supply challenges in the EU’s vaccine procurement program. In January, Hungary became the first nation in the EU to register a Chinese-made Covid-19 vaccine amid very public supply challenges in the EU’s vaccine procurement program. 
On Wednesday, the European Commission president, Ursula von der Leyen, defended Brussels’ decision to lead a collective, EU-wide approach to vaccine procurement and deployment but admitted the body had been overly optimistic and too slow to authorize the jabs. On Wednesday, the European Commission president, Ursula von der Leyen, defended Brussels’ decision to lead a collective, EU-wide approach to vaccine procurement and deployment but admitted the body had been overly optimistic and too slow to authorize the jabs. 
Despite shortcomings in the EU’s inoculation program, Brussels prohibited member nations from making their own deals with vaccine providers. Budapest has elected not to heed its warning.Despite shortcomings in the EU’s inoculation program, Brussels prohibited member nations from making their own deals with vaccine providers. Budapest has elected not to heed its warning.
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.